IP Verse

Medecins Du Monde competitive analysis

Explore patent oppositions filed by Medecins Du Monde against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP3214091	Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	Jul 2, 2019
EP2604620	Modified Fluorinated Nucleoside Analogues	GILEAD PHARMASSET	Mar 27, 2017
EP2203462	Nucleoside Phosphoramidate Prodrugs	GILEAD PHARMASSET	Feb 10, 2015

Discover the latest PTAB cases involving Medecins Du Monde, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Medecins Du Monde with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
MÉDECINS DU MONDE ET AL	2	-	-	-
GILEAD PHARMASSET	-	16	-	10
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	-	51	-	7